Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.45 USD | +0.38% | +4.46% | +15.44% |
May. 09 | Transcript : Phathom Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Phathom Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.44% | 609M | |
+31.49% | 49.46B | |
+0.94% | 42.58B | |
+49.11% | 42.49B | |
-5.26% | 29.09B | |
+12.28% | 26.61B | |
-23.64% | 18.64B | |
+7.24% | 13.16B | |
+31.02% | 12.55B | |
+23.75% | 12.1B |
- Stock Market
- Equities
- PHAT Stock
- News Phathom Pharmaceuticals, Inc.
- Phathom Pharmaceuticals Sees Commercial Launch of Vonoprazan for Erosive Esophagitis, H. Pylori Indications in Q4